Skip to content
Catalyst

lactoferrinFinding

Lactoferrin decreases late-onset sepsis incidence (neonatal)

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Incidence of late-onset sepsis was significantly lower in the BLF and BLF plus LGG groups (9/153 [5.9%] and 7/151 [4.6%], respectively) than in the control group receiving placebo (29/168 [17.3%]) (risk ratio, 0.34; 95% confidence interval, 0.17-0.70; P = .002 for BLF vs control and risk ratio, 0.27; 95% confidence interval, 0.12-0.60; P < .001 for BLF plus LGG vs control).”
Quoted verbatim from Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
This finding among the 3 findings on its endpoint

lactoferrin

Late-onset sepsis incidence (neonatal)

lowers

Effect as reported

0.34risk ratio

CI 0.17 to 0.7

Who
Very low birth weight (<1500 g) neonates in 11 Italian tertiary neonatal intensive care units
Dose studied
100 mg/day orally from birth until day 30 of life (day 45 for neonates <1000 g at birth)

Very limited evidencePMID 19809023 · 2009

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7P6384GR8CTPA5YZ7HYGR9J